Cite
HARVARD Citation
Chiritescu, G. et al. (n.d.). 740PFinal results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC. Annals of oncology. p. . [Online].